Skip to content


Fellows Directory

Peter Sadler

Peter Sadler

Professor Peter Sadler FRS


Elected: 2005


Peter Sadler was one of the first researchers to investigate the chemistry of metals in medicine. Since the 1970s, he has proposed, developed and tested many metal-based drugs, some of which form the core of cancer-fighting drugs commonly used in chemotherapy. Peter has also contributed to treatments for arthritis and reagents for MRI imaging of the body.

He focused his early research on an injectable, gold-containing drug for arthritis, which led to an industrial collaboration to apply such medicines to cancer. He also made significant contributions to platinum-based anticancer drugs, including their synthesis, and subsequently used NMR techniques to examine their mode of action.

More recently, Peter has developed platinum and ruthenium drugs that can be activated — upon exposure to a pulse of light — to precisely target cancers. This has enabled a reduction in their side-effects. He is also interested in catalytic organometallic drugs that can be administered in low doses and destroy cancer cells by new mechanisms involving redox modulation, thus exploiting the defects in the power houses (mitochondria) of cancer cells.

Professional positions

Mok Hing Yiu Distinguished Visiting Professor, The University of Hong Kong
Professor of Chemistry, Department Of Chemistry, University of Warwick

Interest and expertise

Subject groups

  • Chemistry
    • Chemistry, inorganic, Chemistry, biological
  • Biochemistry and molecular cell biology
    • Biochemistry and molecular biology


Inorganic chemistry, Metal coordination chemistry, Bioinorganic chemistry, Medicinal chemistry, Metals in medicine


  • Davy Medal

    For pioneering the research field of medicinal inorganic chemistry, "Metals in Medicine", and the design of new metallodrugs with novel mechanisms of action

Was this page useful?
Thank you for your feedback
Thank you for your feedback. Please help us improve this page by taking our short survey.